Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cristina Meazza & Sebastian Dorin Asaftei. (2021) State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma. Expert Opinion on Pharmacotherapy 22:15, pages 1995-2006.
Read now
Read now
François A. Simard, Iseulys Richert, Alexandra Vandermoeten, Anne-Valérie Decouvelaere, Jean-Philippe Michot, Christophe Caux, Jean-Yves Blay & Aurélie Dutour. (2017) Description of the immune microenvironment of chondrosarcoma and contribution to progression. OncoImmunology 6:2.
Read now
Read now
Marie-Françoise Heymann, Hannah K. Brown & Dominique Heymann. (2016) Drugs in early clinical development for the treatment of osteosarcoma. Expert Opinion on Investigational Drugs 25:11, pages 1265-1280.
Read now
Read now
Winston W Huh, Daniela Egas-Bejar & Peter M Anderson. (2012) New treatment options for nonmetastatic osteosarcoma: focus on mifamurtide in adolescents. Clinical Oncology in Adolescents and Young Adults 2, pages 1-6.
Read now
Read now
Articles from other publishers (96)
Leming Sun, Hongmei Liu, Yanqi Ye, Yang Lei, Rehmat Islam, Sumin Tan, Rongsheng Tong, Yang-Bao Miao & Lulu Cai. (2023) Smart nanoparticles for cancer therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Lisa K. Duong, Halil Ibrahim Corbali, Thomas S. Riad, Shonik Ganjoo, Selene Nanez, Tiffany Voss, Hampartsum Barsomium, James Welsh & Maria Angelica Cortez. (2023) Lipid metabolism in tumor immunology and immunotherapy. Frontiers in Oncology 13.
Crossref
Crossref
Cláudia Martins & Bruno Sarmento. (2023) Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine. WIREs Nanomedicine and Nanobiotechnology.
Crossref
Crossref
David C. Florian, Natalie E. Bennett, Mateusz Odziomek, Jessalyn J. Baljon, Mohamed Wehbe, Alyssa R. Merkel, Melissa A. Fischer, Michael R. Savona, Julie A. Rhoades, Scott A. Guelcher & John T. Wilson. (2023) Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction. Cancer Research Communications 3:2, pages 223-234.
Crossref
Crossref
Namrata Anand, Keng Hee Peh & Jill M. Kolesar. (2023) Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma. International Journal of Molecular Sciences 24:3, pages 2858.
Crossref
Crossref
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti & Massimo Serra. (2023) Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International Journal of Molecular Sciences 24:1, pages 799.
Crossref
Crossref
Federica Banche-Niclot, Ilaria Corvaglia, Caterina Cavalera, Elena Boggio, Casimiro Luca Gigliotti, Umberto Dianzani, Antzela Tzagiollari, Nicholas Dunne, Antonio Manca, Sonia Fiorilli & Chiara Vitale-Brovarone. (2023) Optimization of an Injectable, Resorbable, Bioactive Cement Able to Release the Anti-Osteoclastogenic Biomolecule ICOS-Fc for the Treatment of Osteoporotic Vertebral Compression Fractures. Biomolecules 13:1, pages 94.
Crossref
Crossref
Arundhati Singh, Vedanshi Pal, Shreyshi Aggarwal & Manu Pant. 2023. Secondary Metabolites Based Green Synthesis of Nanomaterials and Their Applications. Secondary Metabolites Based Green Synthesis of Nanomaterials and Their Applications
173
190
.
Lidia Tarone, Katia Mareschi, Elisa Tirtei, Davide Giacobino, Mariateresa Camerino, Paolo Buracco, Emanuela Morello, Federica Cavallo & Federica Riccardo. (2022) Improving Osteosarcoma Treatment: Comparative Oncology in Action. Life 12:12, pages 2099.
Crossref
Crossref
Haibo Wang, Yu He, Meiling Jian, Xingang Fu, Yuheng Cheng, Yujia He, Jun Fang, Lin Li & Dan Zhang. (2022) Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology. Molecules 27:21, pages 7480.
Crossref
Crossref
Juanjuan Yang, Xiaojin Wang, Bingshun Wang, Kinam Park, Karen Wooley & Shiyi Zhang. (2022) Challenging the fundamental conjectures in nanoparticle drug delivery for chemotherapy treatment of solid cancers. Advanced Drug Delivery Reviews 190, pages 114525.
Crossref
Crossref
Lei Yu, Jian Zhang & Yunfeng Li. (2022) Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality. Frontiers in Immunology 13.
Crossref
Crossref
Clément J.F. Heymann, Christine Bobin-Dubigeon, Javier Muñoz-Garcia, Denis Cochonneau, Emilie Ollivier, Marie-Françoise Heymann & Dominique Heymann. (2022) Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients. Journal of Bone Oncology 36, pages 100451.
Crossref
Crossref
Eliza Iwicka, Justyna Hajtuch, Krystyna Dzierzbicka & Iwona Inkielewicz-Stepniak. (2022) Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency. Frontiers in Oncology 12.
Crossref
Crossref
Motoharu Tanaka & Shigeru Abe. (2022) Effects of Liposome-Entrapped Muramyl Tripeptide
Phosphatidylethanolamine (L-MTP-PE) on the Tumor Growth and Survival of Mice
Bearing Syngeneic Tumor in Combination with a Chemotherapeutic or
Immunomodulatory Agent. Drug Research 72:07, pages 372-377.
Crossref
Crossref
Rodrigo dos A. Miguel, Amanda S. Hirata, Paula C. Jimenez, Luciana B. Lopes & Leticia V. Costa-Lotufo. (2022) Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs. Pharmaceutics 14:8, pages 1722.
Crossref
Crossref
Zhongkun Zhang, Siyu Yao, Yingwen Hu, Xiaobin Zhao & Robert J. Lee. (2022) Application of lipid-based nanoparticles in cancer immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Shuhang Wang, Keman Cheng, Kun Chen, Chen Xu, Peiwen Ma, Guohui Dang, Yuqi Yang, Qi Lei, Huiyao Huang, Yue Yu, Yuan Fang, Qiyu Tang, Ning Jiang, Huilei Miao, Funan Liu, Xiao Zhao & Ning Li. (2022) Nanoparticle-based medicines in clinical cancer therapy. Nano Today 45, pages 101512.
Crossref
Crossref
Stefania Kokkali, Ioannis Kotsantis, Elpida Magou, Talagani Sophia, Theodoros Kormas, Giakoumis Diakoumis, Nikolaos Spathas, Amanda Psyrri & Alexandros Ardavanis. (2022) The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis. Investigational New Drugs 40:3, pages 668-675.
Crossref
Crossref
Yubao Lu, Jiahe Zhang, Yutong Chen, Yuchen Kang, Zhipeng Liao, Yuanqi He & Cangyu Zhang. (2022) Novel Immunotherapies for Osteosarcoma. Frontiers in Oncology 12.
Crossref
Crossref
Mohammad Souri, M. Soltani, Farshad Moradi Kashkooli, Mohammad Kiani Shahvandi, Mohsen Chiani, Fatemeh Sadat Shariati, Mohammad Reza Mehrabi & Lance L. Munn. (2022) Towards principled design of cancer nanomedicine to accelerate clinical translation. Materials Today Bio 13, pages 100208.
Crossref
Crossref
Ryan M. Williams, Chintan Kapadia, Edgar A. Jaimes & Daniel A. Heller. 2022. Regenerative Nephrology. Regenerative Nephrology
439
449
.
I. Richert & A. Dutour. 2022. Bone Cancer. Bone Cancer
189
203
.
Sofia Sousa & Jorma A. Määttä. 2022. Bone Cancer. Bone Cancer
205
218
.
Nishant Kumar, Sajid Fazal, Eijiro Miyako, Kazuaki Matsumura & Robin Rajan. (2021) Avengers against cancer: A new era of nano-biomaterial-based therapeutics. Materials Today 51, pages 317-349.
Crossref
Crossref
Maura Argenziano, Chiara Tortora, Elvira Pota, Alessandra Di Paola, Martina Di Martino, Caterina Di Leva, Daniela Di Pinto & Francesca Rossi. (2021) Osteosarcoma in Children: Not Only Chemotherapy. Pharmaceuticals 14:9, pages 923.
Crossref
Crossref
Suhana Ahmad, Ros Akmal Mohd Idris, Wan Nurhidayah Wan Hanaffi, Komathi Perumal, Jennifer C. Boer, Magdalena Plebanski, Juhana Jaafar, Jit Kang Lim & Rohimah Mohamud. (2021) Cancer Nanomedicine and Immune System—Interactions and Challenges. Frontiers in Nanotechnology 3.
Crossref
Crossref
Foad Rommasi & Neda Esfandiari. (2021) Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy. Nanoscale Research Letters 16:1.
Crossref
Crossref
Marie‐Françoise Heymann, Kristina Schiavone & Dominique Heymann. (2020) Bone sarcomas in the immunotherapy era. British Journal of Pharmacology 178:9, pages 1955-1972.
Crossref
Crossref
Mohammad Bayat & Davood Ghaidari. 2021. Nano Drug Delivery Strategies for the Treatment of Cancers. Nano Drug Delivery Strategies for the Treatment of Cancers
119
143
.
Ashwini S. Shinde, Pallavi S. Shinde & Tuhin S. Santra. 2021. Nanomaterials and Their Biomedical Applications. Nanomaterials and Their Biomedical Applications
253
296
.
Zhong-Wei Luo, Pan-Pan Liu, Zhen-Xing Wang, Chun-Yuan Chen & Hui Xie. (2020) Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy. Frontiers in Oncology 10.
Crossref
Crossref
Francesca Cersosimo, Silvia Lonardi, Giulia Bernardini, Brian Telfer, Giulio Eugenio Mandelli, Annalisa Santucci, William Vermi & Emanuele Giurisato. (2020) Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy. International Journal of Molecular Sciences 21:15, pages 5207.
Crossref
Crossref
Mingfa Wang, Tianyu Liu, Xiaowei Hu, Aicong Yin, Jingmin Liu & Xiaoge Wang. (2020) EMP1 promotes the malignant progression of osteosarcoma through the IRX2/MMP9 axis. Panminerva Medica 62:3.
Crossref
Crossref
Ying Zhou, Peter J. Little, Liam Downey, Rizwana Afroz, Yuao Wu, Hang T. Ta, Suowen Xu & Danielle Kamato. (2020) The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease. ACS Pharmacology & Translational Science 3:3, pages 457-471.
Crossref
Crossref
Giulia Chindamo, Simona Sapino, Elena Peira, Daniela Chirio, Mónica Cristina Gonzalez & Marina Gallarate. (2020) Bone Diseases: Current Approach and Future Perspectives in Drug Delivery Systems for Bone Targeted Therapeutics. Nanomaterials 10:5, pages 875.
Crossref
Crossref
Seyed Hossein Kiaie, Solmaz Mojarad-Jabali, Farnaz Khaleseh, Saeideh Allahyari, Elham Taheri, Parvin Zakeri-Milani & Hadi Valizadeh. (2020) Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives. International Journal of Pharmaceutics 581, pages 119269.
Crossref
Crossref
V. S. Nedzvetsky. (2020) THE PEPTIDOGLYCAN FRACTION ENRICHED WITH MURAMYL PENTAPEPTIDE FROM Lactobacillus bulgaricus INHIBITS GLIOBLASTOMA U373MG CELL MIGRATION CAPABILITY AND UPREGULATES PARP1 AND NF-kB LEVELS. Biotechnologia Acta 13:2, pages 65-79.
Crossref
Crossref
Francesca Punzo, Giulia Bellini, Chiara Tortora, Daniela Di Pinto, Maura Argenziano, Elvira Pota, Alessandra Di Paola, Martina Di Martino & Francesca Rossi. (2020) Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells. Oncotarget 11:7, pages 687-698.
Crossref
Crossref
Mohammad Norouzi, Mehrnaz Amerian, Mahshid Amerian & Fatemeh Atyabi. (2020) Clinical applications of nanomedicine in cancer therapy. Drug Discovery Today 25:1, pages 107-125.
Crossref
Crossref
Justin E. Markel, Ryan A. Lacinski & Brock A. Lindsey. 2020. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma
155
168
.
Maxim Yu. Rykov & Elmira R. Sengapova. 2019. Osteosarcoma – Diagnosis, Mechanisms, and Translational Developments. Osteosarcoma – Diagnosis, Mechanisms, and Translational Developments.
Leila Martinez Beltrán, Daniel Ozaeta Eidelman & Natalia Lucía González Suárez. (2019) Caracterización de los niños con osteosarcoma no metastásico quienes recibieron tratamiento con mifamurtida en dos instituciones de Bogotá (Colombia) entre 2014 y 2017. Universitas Médica 60:4, pages 1-8.
Crossref
Crossref
Marie-Françoise Heymann, Frédéric Lézot & Dominique Heymann. (2019) The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. Cellular Immunology 343, pages 103711.
Crossref
Crossref
Gangyang Wang, Mengxiong Sun, Yafei Jiang, Tao Zhang, Wei Sun, Hongsheng Wang, Fei Yin, Zhuoying Wang, Weilin Sang, Jing Xu, Min Mao, Dongqing Zuo, Zifei Zhou, Chongren Wang, Zeze Fu, Zongyi Wang, Zhenfeng Duan, Yingqi Hua & Zhengdong Cai. (2019)
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis
via
dual blockade of VEGFR2 and MET in osteosarcoma
. International Journal of Cancer 145:4, pages 979-993.
Crossref
Crossref
M. Yu. Rykov & E. R. Sengapova. (2019) Osteosarcoma – on the way to personalized therapy. Part II: personalized therapy of the future. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 64:3, pages 28-36.
Crossref
Crossref
Prashant Dogra, Joseph D. Butner, Yao-li Chuang, Sergio Caserta, Shreya Goel, C. Jeffrey Brinker, Vittorio Cristini & Zhihui Wang. (2019) Mathematical modeling in cancer nanomedicine: a review. Biomedical Microdevices 21:2.
Crossref
Crossref
Panagiotis Tsagozis, Martin Augsten, Yifan Zhang, Tian Li, Asle Hesla, Jonas Bergh, Felix Haglund, Nicholas P. Tobin & Monika Ehnman. (2019) An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma. Cancer Immunology, Immunotherapy 68:6, pages 927-936.
Crossref
Crossref
Karina Ovejero Paredes, Jesús Ruiz-Cabello, David Izquierdo Alarcón & Marco Filice. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics
421
456
.
Claudia Pasqualini, Fanny Rialland, Dominique Valteau-Couanet, Jean Michon & Véronique Minard-Colin. (2018) Nouvelles perspectives dans l’immunothérapie des cancers pédiatriques. Bulletin du Cancer 105, pages S68-S79.
Crossref
Crossref
Mary Frances Wedekind, Nicholas L. Denton, Chun-Yu Chen & Timothy P. Cripe. (2018) Pediatric Cancer Immunotherapy: Opportunities and Challenges. Pediatric Drugs 20:5, pages 395-408.
Crossref
Crossref
Roger Gilabert-Oriol, Gemma Ryan, Ada Leung, Natalie Firmino, Kevin Bennewith & Marcel Bally. (2018) Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response. International Journal of Molecular Sciences 19:10, pages 2922.
Crossref
Crossref
Nurdan Tacyildiz, Sonay Incesoy Ozdemir, Emel Unal, Melda Berber, Handan Dincaslan & Gulsan Yavuz. (2018) The Efficiency and Toxicity of Mifamurtide in Childhood Osteosarcoma. Journal of Pediatric Hematology/Oncology 40:6, pages e373-e376.
Crossref
Crossref
Sin-Yeang Teow, Magdelyn Wong, Hooi-Yeen Yap, Suat-Cheng Peh & Kamyar Shameli. (2018) Bactericidal Properties of Plants-Derived Metal and Metal Oxide Nanoparticles (NPs). Molecules 23:6, pages 1366.
Crossref
Crossref
Rincy Jimmy, Cindy Stern, Karolina Lisy & Sarahlouise White. (2017) Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 15:8, pages 2113-2152.
Crossref
Crossref
Suhua Wang, Jingshu Yang, Xueyuan Li, Zijie Liu, Youzhen Wu, Guangxu Si, Yiran Tao, Nan Zhao, Xiao Hu, Yao Ma & Gang Liu. (2017) Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo. Journal of Medicinal Chemistry 60:12, pages 5162-5192.
Crossref
Crossref
Carl T. Gustafson, Tewodros Mamo, Kristen L. Shogren, Avudaiappan Maran & Michael J. Yaszemski. (2017) FH535 Suppresses Osteosarcoma Growth In Vitro and Inhibits Wnt Signaling through Tankyrases. Frontiers in Pharmacology 8.
Crossref
Crossref
Zhengxiang Huang, Guojun Fan & Dongliang Wang. (2017) Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells. Oncology Letters 13:5, pages 3727-3733.
Crossref
Crossref
Marie-Françoise Heymann & Dominique Heymann. 2017. Osteosarcoma - Biology, Behavior and Mechanisms. Osteosarcoma - Biology, Behavior and Mechanisms.
Anfal Jasim, Sara Abdelghany & Khaled Greish. 2017. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes
62
109
.
Patrick Dutartre. (2016) Inflammasomes and Natural Ingredients towards New Anti-Inflammatory Agents. Molecules 21:11, pages 1492.
Crossref
Crossref
Christina K Lettieri, Nicole Appel, Nicole Labban, Danielle M Lussier, Joseph N Blattman & Pooja Hingorani. (2016) Progress and opportunities for immune therapeutics in osteosarcoma. Immunotherapy 8:10, pages 1233-1244.
Crossref
Crossref
Aaron C. Anselmo & Samir Mitragotri. (2016) Nanoparticles in the clinic. Bioengineering & Translational Medicine 1:1, pages 10-29.
Crossref
Crossref
Lisa Bregoli, Dania Movia, James D. Gavigan-Imedio, Joanne Lysaght, John Reynolds & Adriele Prina-Mello. (2016) Nanomedicine applied to translational oncology: A future perspective on cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine 12:1, pages 81-103.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
1032
.
Hyun Jin Song, Jun Ah Lee, Euna Han & Eui-Kyung Lee. (2015) Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis. Tumor Biology 36:9, pages 6773-6779.
Crossref
Crossref
Edgar Pérez-Herrero & Alberto Fernández-Medarde. (2015) Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European Journal of Pharmaceutics and Biopharmaceutics 93, pages 52-79.
Crossref
Crossref
D. R. Killick, A. J. Stell & B. Catchpole. (2015) Immunotherapy for canine cancer - Is it time to go back to the future?. Journal of Small Animal Practice 56:4, pages 229-241.
Crossref
Crossref
Pavlína Turánek Knotigová, Daniel Zyka, Josef Mašek, Anna Kovalová, Michal Křupka, Eliška Bartheldyová, Pavel Kulich, Štěpán Koudelka, Róbert Lukáč, Zuzana Kauerová, Antonín Vacek, Milada Stuchlová Horynová, Alois Kozubík, Andrew D. Miller, Ladislav Fekete, Irena Kratochvílová, Jan Ježek, Miroslav Ledvina, Milan Raška & Jaroslav Turánek. (2015) Molecular Adjuvants Based on Nonpyrogenic Lipophilic Derivatives of norAbuMDP/GMDP Formulated in Nanoliposomes: Stimulation of Innate and Adaptive Immunity. Pharmaceutical Research 32:4, pages 1186-1199.
Crossref
Crossref
Kun Shao, Santiswarup Singha, Xavier Clemente-Casares, Sue Tsai, Yang Yang & Pere Santamaria. (2014) Nanoparticle-Based Immunotherapy for Cancer. ACS Nano 9:1, pages 16-30.
Crossref
Crossref
Takenori Uehara, Tomohiro Fujiwara, Ken Takeda, Toshiyuki Kunisada, Toshifumi Ozaki & Heiichiro Udono. (2015) Immunotherapy for Bone and Soft Tissue Sarcomas. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Stella Maris de Freitas Lima, Gabriela Martins de Pádua, Maurício Gonçalves da Costa Sousa, Mirna de Souza Freire, Octávio Luiz Franco & Taia Maria Berto Rezende. (2015) Antimicrobial peptide-based treatment for endodontic infections — Biotechnological innovation in endodontics. Biotechnology Advances 33:1, pages 203-213.
Crossref
Crossref
Sofia Sousa & Jorma A. Määttä. 2015. Bone Cancer. Bone Cancer
91
101
.
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref
Audrey Lamora, Julie Talbot, Gwenola Bougras, Jérôme Amiaud, Marion Leduc, Julie Chesneau, Julien Taurelle, Verena Stresing, Marie Cécile Le Deley, Marie Françoise Heymann, Dominique Heymann, Françoise Redini & Franck Verrecchia. (2014) Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research 20:19, pages 5097-5112.
Crossref
Crossref
Hyun Jin Song, Eui-Kyung Lee, Jun Ah Lee, Hye-Lin Kim & Kyoung Won Jang. (2014) The addition of mifamurtide to chemotherapy improves lifetime effectiveness in children with osteosarcoma: a Markov model analysis. Tumor Biology 35:9, pages 8771-8779.
Crossref
Crossref
Sergei R. Guma, Dean A. Lee, Yu Ling, Nancy Gordon & Eugenie S. Kleinerman. (2014) Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis. Pediatric Blood & Cancer 61:8, pages 1362-1368.
Crossref
Crossref
Hayley Nehoff, Neha N. Parayath, Sebastien Taurin & Khaled Greish. 2014. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology
65
86
.
P.M. Anderson, P. Meyers, E. Kleinerman, K. Venkatakrishnan, D.P. Hughes, C. Herzog, W. Huh, R. Sutphin, Y.M. Vyas, V. Shen, A. Warwick, N. Yeager, C. Oliva, B. Wang, Y. Liu & A. Chou. (2013) Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments. Pediatric Blood & Cancer 61:2, pages 238-244.
Crossref
Crossref
Rincy Jimmy, Sarahlouise White & Karolina Lisy. (2014) Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 12:11, pages 61-73.
Crossref
Crossref
Irena Adkins. 2014. Molecular Vaccines. Molecular Vaccines
537
549
.
Jaroslav Turánek, Josef Mašek, Michal Křupka & Milan Raška. 2014. Molecular Vaccines. Molecular Vaccines
561
577
.
Gábor Mezo. 2013. Amino Acids, Peptides and Proteins. Amino Acids, Peptides and Proteins
203
252
.
Shayne Cox GadHayley Nehoff, Sebastien Taurin & Khaled Greish. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Steven Georges, Julie Chesneau, Soizic Hervouet, Julien Taurelle, François Gouin, Françoise Redini, Marc Padrines, Dominique Heymann, Yannick Fortun & Franck Verrecchia. (2013) A Disintegrin And Metalloproteinase 12 produced by tumour cells accelerates osteosarcoma tumour progression and associated osteolysis. European Journal of Cancer 49:9, pages 2253-2263.
Crossref
Crossref
Kosei Ando, Marie-Françoise Heymann, Verena Stresing, Kanji Mori, Françoise Rédini & Dominique Heymann. (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers 5:4, pages 591-616.
Crossref
Crossref
P. KatonisG. DatsisA. KarantanasA. KampouroglouS. LianoudakisS. LicoudisE. PapoutsopoulouK. Alpantaki. (2013) Spinal Osteosarcoma. Clinical Medicine Insights: Oncology 7, pages CMO.S10099.
Crossref
Crossref
Zhaoxu Li. (2012) Potential of human γδ T cells for immunotherapy of osteosarcoma. Molecular Biology Reports 40:1, pages 427-437.
Crossref
Crossref
Sebastien Taurin & Khaled Greish. 2013. Tight Junctions in Cancer Metastasis. Tight Junctions in Cancer Metastasis
81
118
.
Sebastien Taurin, Hayley Nehoff, Thalita van Aswegen & Khaled Greish. 2013. Cancer Targeted Drug Delivery. Cancer Targeted Drug Delivery
207
239
.
Sebastien Taurin, Hayley Nehoff & Khaled Greish. (2012) Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?. Journal of Controlled Release 164:3, pages 265-275.
Crossref
Crossref
Katherine A. Janeway & Robert G. Maki. (2012) New Strategies in Sarcoma Therapy: Linking Biology and Novel Agents. Clinical Cancer Research 18:21, pages 5837-5844.
Crossref
Crossref
ANNE-SOPHIE HÖNICKE, STEPHAN ALBRECHT ENDER & JÜRGEN RADONS. (2012) Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells. International Journal of Oncology 41:2, pages 753-758.
Crossref
Crossref
François Coulombe, Stéphanie Fiola, Shizuo Akira, Yvon Cormier & Jean Gosselin. (2012) Muramyl Dipeptide Induces NOD2-Dependent Ly6Chigh Monocyte Recruitment to the Lungs and Protects Against Influenza Virus Infection. PLoS ONE 7:5, pages e36734.
Crossref
Crossref
Gatien Moriceau, Anke J. Roelofs, Régis Brion, Françoise Redini, Frank H. Ebetion, Michael J. Rogers & Dominique Heymann. (2011) Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer 118:3, pages 750-760.
Crossref
Crossref
Joanne Bronson, Murali Dhar, William Ewing & Nils Lonberg. 2011.
433
502
.